SNDX 8-K 2026-07-14

Syndax Pharmaceuticals Inc (SNDX) 8-K dated 2026-07-14 — accession 0001193125-26-302608. This URL is the filing, not the SNDX hub.

Syndax Pharmaceuticals Inc (SNDX) is a biotechnology company listed on US.

Syndax Pharmaceuticals Inc filed a 8-K on 2026-07-14. Accession 0001193125-26-302608.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SNDX revenue for 2025-12-31 was $172.4M. Net income was -$285.4M. Revenue was up 627.8% from 2024-12-31 to 2025-12-31. SNDX currently screens at market cap $774.4M.

Not investment advice. The SNDX SEC hub lists recent forms. The stock page is the research view.